Centuria Capital Group (CNI)
Australian Securities Exchange · Australia · prices in AUD · close of 27 Oct 2026
Key indicators
| Last close | AUD 1.120 |
|---|---|
| 52-week range | 1.025 – 2.440 |
| Return, 1 month / 3 months | −8.6% / −25.3% |
| Return, 1 year / 3 years | −50.7% / +12.2% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 37.5% |
| Worst drawdown (1 year) | -53.3% |
| Average daily value traded | 5.30M AUD |
| Dividend yield | 9.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Centuria Capital Group is an Australian investment manager focused on property. It creates and manages property funds, pooling money from investors to own industrial, office and healthcare real estate, and it also invests its own capital alongside those investors. Its customers include institutional and retail investors who want exposure to commercial property through pooled vehicles. The company is based in Australia and earns fees for managing these funds and their assets.
On this site Centuria Capital Group appears as a stock on the Australian Securities Exchange (Australia), code CNI, with prices in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Centuria Capital Group (CNI) trades on the Australian Securities Exchange in Australia. It last closed at AUD 1.120 on 27 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 862 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 50.7% and over the last three months it fell 25.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 28 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -30.3% | ||
| From 52-week high | -53.5% | ||
| Momentum | 26 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -25.3% | ||
| 6-month return | -30.8% | ||
| 12-month return, skipping the last month | -46.0% | ||
| Stability (higher is calmer) | 66 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 37.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -53.3% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 5.30M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 90 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 9.3% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +2.3% |
|---|---|
| 1 month | −8.6% |
| 3 months | −25.3% |
| 6 months | −30.8% |
| 1 year | −50.7% |
| 3 years | +12.2% |
| 5 years | −55.8% |
Signals
| 50-day / 200-day average | 1.222 / 1.608 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.045 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Jun 2026 | AUD 0.0520 |
| 30 Dec 2025 | AUD 0.0518 |
| 27 Jun 2025 | AUD 0.0518 |
| 30 Dec 2024 | AUD 0.0518 |
| 27 Jun 2024 | AUD 0.0498 |
| 28 Dec 2023 | AUD 0.0498 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.